Invention Grant
- Patent Title: Antiviral oxime phosphoramide compounds
-
Application No.: US16061732Application Date: 2016-12-12
-
Publication No.: US10450335B2Publication Date: 2019-10-22
- Inventor: Wenlang Fu , Zhiqiang Guo , Ning Qi , Izzat T. Raheem , Petr Vachal , Ming Wang , John D. Schreier
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Eric A. Meade; John C. Todaro
- International Application: PCT/US2016/066075 WO 20161212
- International Announcement: WO2017/106069 WO 20170622
- Main IPC: C07F9/655
- IPC: C07F9/655 ; A61K31/675 ; A61P31/18 ; C07F9/6561 ; A61K45/06

Abstract:
Compounds of Formula I: I and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
Public/Granted literature
- US20180362563A1 ANTIVIRAL OXIME PHOSPHORAMIDE COMPOUNDS Public/Granted day:2018-12-20
Information query